A student from Henley College has died after contracting meningitis, as health authorities work to contain a small cluster of cases in the Reading area. Two other young people, students at Reading Blue Coat School and Highdown Secondary School and Sixth Form Centre, are being treated for the infection. The UK Health Security Agency (UKHSA) confirmed the three cases of meningococcal disease on Thursday, and said close contacts have been offered precautionary antibiotics.
Hart Surgery in Henley-on-Thames, the GP practice that confirmed the death, said the UKHSA was actively contacting those who may have been in close association with the student. “If you have not been contacted by the UK Health Security Agency, then currently you do not require any treatment,” the surgery said in a statement, adding that staff and students had been advised they could attend the college as usual.
The UKHSA has confirmed that the strain identified in the first case is Meningitis B (MenB), but stressed that it is not the same substrain responsible for the fatal outbreak in Kent earlier this year. That outbreak, linked to a nightclub in Canterbury, claimed the lives of two young people – 18-year-old Juliette Kenny, described by her family as “fit, healthy and strong”, and a University of Kent student. It was described as the largest cluster of meningitis cases in a generation.
Dr Rachel Mearkle, a consultant in health protection at the UKHSA, said: “We understand that many people will be affected by this sad news and would like to offer our condolences to the friends and family of this student.” She emphasised that while the news would naturally cause concern, meningococcal meningitis requires very close contact to spread, and large outbreaks remain rare.
How meningitis spreads and why the public risk is low
Meningococcal disease is caused by bacteria that can live harmlessly in the nose or throat of a person who becomes a “carrier”. The bacteria do not spread easily. Transmission typically requires prolonged, close contact – living in the same household, intimate contact such as kissing, sharing drinks or vapes, or spending time in crowded settings. This means the infection is far less contagious than viruses such as measles or COVID-19.
“The number of confirmed cases is very low, so there are currently no plans for a local emergency meningitis vaccination programme,” the Hart Surgery added. The UKHSA has consistently said the risk to the wider public remains low, a message echoed by Dr Mearkle: “Meningococcal disease does not spread easily, and the risk to the wider public remains low.”
Meningitis is most common in babies, young children, teenagers and young adults. Teenagers and university students are considered at increased risk because of close social contact. While the MenACWY vaccine is routinely offered to secondary school students (Years 9 and 10) and remains free on the NHS until age 25, the MenB vaccine – despite being available for infants since 2015 – has not been routinely offered to older teenagers and young adults, meaning many in this age group may not have received protection against the B strain unless they bought it privately.
In recent years, other clusters have been identified. Three cases of MenB were confirmed in Weymouth, Dorset, in April 2026 – a different substrain from the Kent outbreak. A viral meningitis cluster occurred in Nottinghamshire secondary schools in 2018, and localised school and youth clusters were reported in Belfast and Northern Ireland in 2022. Globally, an estimated quarter of a million people died from meningitis in 2023, with more than a third of those deaths in children under five.
Health officials urge anyone concerned to be aware of the symptoms, which can appear in any order and may not all be present: high temperature, severe headache, vomiting, stiff neck, sensitivity to light, confusion, drowsiness, cold hands and feet, muscle and joint pain, a rash that does not fade under pressure (which can be harder to see on darker skin), rapid breathing, and fits. Meningitis can become life-threatening very quickly, and early diagnosis and treatment are vital. Anyone with concerns should seek urgent medical attention by calling 999 or 111.
